T-Cell Associated Antigen-Positive B-Cell Lymphoma

References

• Borowitz M. J., Bousvaros A., Brynes R. K., Cousar J. B., Crissman J. D., Whitcomb C. C., Kerns B. J., Byrne G.E., Jr. Monoclonal antibody phenotyping of B-cell non-Hodgkin's lymphomas. The Southeastern Cancer Study Group experience. American Journal of Pathology 1985; 121: 514–521
   PubMed Web of Science ®Google Scholar
• Foon K. A., Todd R. F. 3d. Immunologic classification of leukemia and lymphoma. Blood 1986; 68: 1–31
   PubMed Web of Science ®Google Scholar
• Norton A. J., Isaacson P. G. Detailed phenotypic analysis of B-cell lymphoma using a panel of antibodies reactive in routinely fixed wax-embedded tissue. American Journal of Pathology 1987; 128: 225–240
   PubMed Web of Science ®Google Scholar
• Schuurman H. J., Huppes W., Verdonck L. F., van Baarlen J., van Unnik J. A. Immunophenotyping of non-Hodgkin's lymphoma. Correlation with relapse-free survival. American Journal of Pathology 1988; 131: 102–111
   PubMed Web of Science ®Google Scholar
• Cousar J. B. Surgical pathology examination of lymph nodes. American Journal of Clinical Pathology 1995; 104: 126–132
   PubMed Web of Science ®Google Scholar
• Tbakni A., Edinger M., Myles J., Pohlman B., Tubbs R. R. Flow cytometric immunophenotyping of non-Hodgkin's lymphoma and related disorders. Cytometry 1996; 25: 113–124
   PubMedGoogle Scholar
• Ichinohasama R., DeCoteau J. F., Myers J., Kadin M. E., Sawai T., Ooya K. Three-color flow cytometry in the diagnosis of malignant lymphoma based on the comparative cell morphology of lymphoma cells and reactive lymphocytes. Leukemia 1997; 11: 1891–1903
   PubMed Web of Science ®Google Scholar
• Jennings C. D., Foon K. A. Recent advances in flow cytometry: Application to the diagnosis of hematologic malignancy. Blood 1997; 90: 2863–2892
   PubMed Web of Science ®Google Scholar
• Harris N. L., Jaffe E. S., Stein H., Banks P. M., Chan J. K.C., Cleary M. L., Delsol G., Wolf-Peeters C. D., Falini B., Gatter K. C., Grogan T. M., Isaacson P. G., Knowles D. M., Mason D. Y., Muller-Hermelink H. K., Pileri S. A., Piris M. A., Ralfkiaer E., Warnke R. A. A revised European-American classification of lymphoid neoplasms: A proposal from the international lymphoma study group. Blood 1994; 84: 1361–1392
   PubMed Web of Science ®Google Scholar
• Harris N. L., Jaffe E. S., Diebold J., Flandrin G., Muller-Hermelink H. K., Vardiman J., Lister T. A., Bloomfield C. D. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the clinical advisory committee meeting-airlie house, Virginia, November 1997. Journal of Clinical Oncology 1999; 17: 3835–3849
   PubMed Web of Science ®Google Scholar
• Sun T., Susin M. A practical approach to immunophenotyping of lymphoma. Comparison of immunohistologic and immunocytologic techniques. Annals of Clinical and Laboratory Science 1987; 17: 14–26
   PubMed Web of Science ®Google Scholar
• Picker L. J., Weiss L. M., Medeiros L. J., Wood G. S., Warnke R. A. Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma. American Journal of Pathology 1987; 128: 181–201
   PubMed Web of Science ®Google Scholar
• Spier C. M., Grogan T. M., Lippman S. M., Slymen D. S., Rybski J. A., Miller T. P. The aberrancy on immunophenotype and immunoglobulin status as indicators of prognosis in B cell diffuse large cell lymphoma. American Journal of Pathology 1988; 133: 118–126
   PubMed Web of Science ®Google Scholar
• Aisenberg A. C., Bloch K. J., Wilkes B. M. Malignant lymphoma with dual B and T cell markers. Analysis of the neoplastic cells with monoclonal antibodies directed against T cell subsets. Journal of Experimental Medicine 1981; 154: 1709–1714
   PubMed Web of Science ®Google Scholar
• Schuurman H. J., van Baarlen J., Huppes W., Lam B. W., Verdonck L. F., van Unnik J. A.M. Immunophenotyping of non-Hodgkin's lymphoma. Lack of correlation between immunophenotype and cell morphology. American Journal of Pathology 1987; 129: 140–151
   PubMed Web of Science ®Google Scholar
• Schmidt C. J., Domenico L., Ward P., Barcos M. P., Stewart C. C. Aberrant antigen expression detected by multiparameter three color flow cytometry in intermediate and high grade B-cell lymphomas. Leukemia and Lymphoma 1999; 34: 539–544
   PubMed Web of Science ®Google Scholar
• Inaba T., Shimazaki C., Sumikuma, Okano A., Hatsuse M., Okamoto A., Takahashi R., Ashihara E., Hibi S., Sudo Y., Yamagata N., Murakami S., Rin K., Fujita N., Yoshimura M., Nakagawa M. Expression of T-cell-associated antigens in B-cell non-Hodgkin's lymphoma. British Journal of Haematology 2000; 109: 592–599
   PubMed Web of Science ®Google Scholar
• Rosenberg S. A. National Cancer Institute sponsored study of classification of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage. Cancer 1982; 49: 2112–2135
   PubMed Web of Science ®Google Scholar
• Delia D., Cattoretti G., Polli N., Fontanella E., Aiello A., Giardini R., Rilke F., Porta D. G. CD1c but neither CD1a nor CD1b molecules are expressed on normal, activated, and malignant human B cells: Identification of a new B cell subset. Blood 1988; 72: 241–247
   PubMed Web of Science ®Google Scholar
• McMichael A. J., Pilch J. R., Galfre G., Mason D. Y., Fabre J. W., Milstein C. A human thymocyte antigen defined by a hybrid myeloma monoclonal antibody. European Journal of Immunology 1979; 9: 205–210
   PubMed Web of Science ®Google Scholar
• Orazi A., Cattoretti G., Polli N., Rilke F. Distinct morphophenotypic features of chronic B-cell leukaemias identified with CD1c and CD23 antibodies. European Journal of Haematology 1991; 47: 28–35
   PubMed Web of Science ®Google Scholar
• Merle-Beral H., Boumsell L., Michel A., Debre P. CD1 expression on B-CLL lymphocytes. British Journal of Haematology 1989; 71: 209–212
   PubMed Web of Science ®Google Scholar
• Jones R. A., Master P. S., Child J. A., Roberts B. E., Scott C. S. Diagnostic differentiation of chronic B-cell malignancies using monoclonal antibody L161 (CD1c). British Journal of Haematology 1989; 71: 43–46
   PubMed Web of Science ®Google Scholar
• Moingeon P., Chang H. C., Sayre P. H., Clayton L. K., Alcover A., Gardner P., Reinherz E. L. The structural biology of CD2. Immunological Reviews 1989; 111: 111–144
   PubMed Web of Science ®Google Scholar
• Sitia R., Sciariada L., Zicca A., Leprini A., Ghio R., Ferrarini M. Expression of a receptor for sheep erythrocytes by B lymphocytes from a chronic lymphocytic leukemia. Clinical Immunology and Immunopathology 1983; 27: 210–222
   PubMedGoogle Scholar
• Viciana A. L., Lancet F. C., Chamizo W., Voigt W., Ruiz P. Simultaneous expression of CD2 on B-cell, small lymphocytic neoplasm. Cytometry 1994; 18: 42–48
   PubMedGoogle Scholar
• Brohee D., Cauchie P., Neve P. Co-expression of CD2 or CD8 antigens in B-cell chronic lymphocytic leukaemia. A flow cytometry analysis of 3 cases. Acta Clinica Belgica 1994; 49: 183–186
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Muraguchi A., Ledbetter J. A., Kishimoto T., O'Brien R. T., Roloff J. S., Gajl-Peczalska K., Provisor G., Koller B. Biphenotypic leukemic lymphocyte precursors in CD2+ CD19+ acute lymphoblastic leukemia and their putative normal counterparts in human fetal hematopoietic tissues. Blood 1989; 73: 1000–1015
   PubMed Web of Science ®Google Scholar
• Cantu-Rajnoldi A., Putti M. C., Schiro R., Biondi A., Cattoretti G., Valeggio C., Castagni M., Basso G. Biological and clinical features of B-precursor childhood acute lymphoblastic leukemia showing CD2 and/or E-rosette co-expression. Haematologica 1992; 77: 384–391
   PubMed Web of Science ®Google Scholar
• Dunphy C. H., Chu J. Y. Aberrant CD2 expression in precursor-B acute lymphoblastic leukemia of childhood. American Journal of Hematology 1996; 52: 224–226
   PubMed Web of Science ®Google Scholar
• Guglielmi C., Martelli M. P., Diverio D., Fenu S., Vegna M. L., Rajnoldi A. C., Biondi A., Cocito M. G., Vecchio L. D., Tabilio A., Avvisati G., Basso G., Coco F. L. Immunophenotype of adult and childhood acute promyelocytic leukaemia: Correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases. British Journal of Haematology 1998; 102: 1035–1041
   PubMed Web of Science ®Google Scholar
• Clevers H., Alarcon B., Wileman T., Terhorst C. The T cell receptor/CD3 complex: A dynamic protein ensemble. Annual Review of Immunology 1988; 6: 629–662
   PubMed Web of Science ®Google Scholar
• Parnes J. R. Molecular biology and function of CD4 and CD8. Advances in Immunology 1989; 44: 265–331
   PubMed Web of Science ®Google Scholar
• Wang C. Y., Good R. A., Ammirati P., Dymbort G., Evans R. L. Identification of a p69,71 complex expressed on human T cells sharing determinants with B-type chronic lymphatic leukemia cells. Journal of Experimental Medicine 1980; 515: 1539–1544
   Web of Science ®Google Scholar
• Martin P. J., Hansen J. A., Nowinski R. C., Brown M. A. A new human T-cell differentiation antigen: unexpected expression on chronic lymphatic leukemia cells. Immunogenetics 1980; 11: 429–439
   PubMed Web of Science ®Google Scholar
• Boumsell L., Coppin H., Pham D., Raynal B., Lemerle J., Dausset J., Bernard A. An antigen shared by a human T cell subset and B cell chronic lymphocytic leukemia cells: Distribution on normal and malignant lymphoid cells. Journal of Experimental Medicine 1980; 152: 229–234
   PubMed Web of Science ®Google Scholar
• Wormsley S. B., Collins M. L., Royston I. Comparative density of the human T-cell antigen T65 on normal peripheral blood T cells and chronic lymphocytic leukemia. Blood 1981; 57: 657–662
   PubMed Web of Science ®Google Scholar
• Schroff R. W., Foon K. A., Billing R. J., Fahey J. L. Immunologic classification of lymphatic leukemias based on monoclonal antibody-defined cell surface antigens. Blood 1982; 59: 207–215
   PubMedGoogle Scholar
• Kamoun M., Kadin M.E., Martin P. J., Nettleton J., Hansen J. A. A novel human T cell antigen preferentially expressed on mature T cells and shared by both well and poorly differentiated B cell leukemias and lymphomas. Journal of Immunology 1981; 127: 987–991
   PubMed Web of Science ®Google Scholar
• Foon K. A., Schroff R. W., Gale R. P. Surface markers on leukemia and lymphoma cell: Recent advances. Blood 1982; 60: 1–19
   PubMed Web of Science ®Google Scholar
• Knowles D. M., Jakobiec F. A., Wang C. Y. The expression of surface antigen Leu-1 by ocular adnexal lymphoid neoplasms. American Journal of Ophthalmology 1982; 94: 246–254
   PubMed Web of Science ®Google Scholar
• Stein H., Gerdes J., Mason D. Y. The normal and malignant germinal center. Clinical Haematology 1982; 11: 531–559
   PubMedGoogle Scholar
• Burns B. F., Warnke R. A., Doggett R. S., Rouse R. V. Expression of a T-cell antigen (Leu-1) by B-cell lymphoma. American Journal of Pathology 1983; 113: 165–171
   PubMed Web of Science ®Google Scholar
• Knowles D. M. 2d, Halper J. P., Azzo W., Wang CY. Reactivity of monoclonal antibodies Leu 1 and OKT1 with malignant human lymphoid cells. Correlation with conventional cell markers. Cancer 1983; 52: 1369–1377
   PubMed Web of Science ®Google Scholar
• Delia D., Bonati A., Giardini R., Villa S., De Braud F., Cattoretti G., Rilke F. Expression of the T1(CD5, p67) surface antigen in B-CLL and B-NHL and its correlation with other B-cell differentiation markers. Hematology Oncology 1986; 4: 237–248
   PubMed Web of Science ®Google Scholar
• Weisenburger D. D., Linder J., Daley D. T., Armitage J. O. Intermediate lymphocytic lymphoma. An immunohistologic study with comparison to other lymphocytic lymphomas. Human Pathology 1987; 18: 781–790
   PubMed Web of Science ®Google Scholar
• Strickler J. G., Medeiros L. J., Copenhaver C. M., Weiss L. M., Warnke R. A. Intermediate lymphocytic lymphoma: An immunophenotypic study with comparison to small lymphocytic lymphoma and diffuse small cleaved cell lymphoma. Human Pathology 1988; 19: 550–554
   PubMed Web of Science ®Google Scholar
• Lardelli P., Bookman M. A., Sundeen J., Longo D. L., Jaffe E. S. Lymphocyitc lymphoma of intermediate differentiation. Morphologic and immunophenotypic spectrum and clinical correlations. American Journal of Surgical Pathology 1990; 14: 752–763
   PubMed Web of Science ®Google Scholar
• Dighiero G., Travade P., Chevret S., Fenaux P., Chastang C., Binet J. L., The French Cooperative Group on CLL. B-cell chronic lymphocytic leukemia: Present status and future directions. Blood 1991; 78: 1901–1914
   PubMed Web of Science ®Google Scholar
• Banks P. M., Chan J., Clearly M. L., Delsol G., De Wolf-Peeters C., Gatter K., Grogan T. M., Harris N. H., Isaacson P. G., Jaffe E. S., Mason D., Pileri S., Ralfkiaer E., Stein H., Warnke R. A. Mantle cell lymphoma: A proposal for unification of morphologic, immunologic, and molecular data. American Journal of Surgical Pathology 1992; 16: 637–640
   PubMed Web of Science ®Google Scholar
• Kurec A. S., Threatte G. A., Gottlieb A. J., Smith J. R., Anderson J., Davey F. R. Immunophenotypic classification of chronic (mature) B and T lymphoid leukaemia. British Journal of Haematology 1992; 42: 567–584
   Google Scholar
• Matolcsy A., Chadburn A., Knowles D. M. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct. American Journal of Pathology 1995; 147: 207–216
   PubMed Web of Science ®Google Scholar
• Sonoki T., Matsuzaki H., Asou N., Hata H., Matsuno F., Yoshida M., Nagasaki A., Kuribayashi N., Kudo H., Takatsuki K. Aggressive CD5-positive diffuse large B cell lymphoma showing c-myc rearrangements developed in a patient with autoimmune hemolytic anemia. International Journal of Hematology 1996; 63: 71–76
   PubMed Web of Science ®Google Scholar
• Yatabe Y., Nakamura S., Seto M., Kuroda H., Kagami Y., Suzuki R., Ogura M., Kojima M., Koshikawa T., Ueda R., Suchi T. Clinicopathologic study of PRAD1/cyc-lin D1 overexpressing lymphoma with special reference to mantle cell lymphoma. A distinct molecular pathologic entity. American Journal of Surgical Pathology 1996; 20: 1110–1122
   PubMed Web of Science ®Google Scholar
• Kume M., Suzuki R., Yatabe Y., Kagami Y., Miura I., Miura A. B., Morishima Y., Nakamura S., Seto M. Somatic hypermutations in the VH segment of immunoglobulin genes of CD5-positive diffuse large B-cell lymphoma. Japanese Journal of Cancer Research 1997; 88: 1087–1093
   PubMedGoogle Scholar
• Taniguchi M., Oka K., Hiasa A., Yamaguchi M., Ohno T., Kita K., Shiku H. De novo CD5+ diffuse large B-cell lymphomas express VH genes with somatic mutation. Blood 1998; 91: 1145–1151
   PubMed Web of Science ®Google Scholar
• Harada S., Suzuki R., Uehira K., Yatabe Y., Kagami Y., Ogura M., Suzuki H., Oyama A., Kodera Y., Ueda R., Morishima Y., Nakamura S., Seto M. Molecular and immunological dissection of diffuse large B cell lymphoma: CD5+, and CD5-with CD10+ groups may constitute clinically relevant subtypes. Leukemia 1999; 13: 1441–1447
   PubMed Web of Science ®Google Scholar
• Yamaguchi M., Ohno T., Oka K., Taniguchi M., Ito M., Kita K., Shiku H. De novo CD5-positive diffuse large B-cell lymphoma: Clinical characteristics and therapeutic outcome. British Journal of Haematology 1999; 105: 1133–1139
   PubMed Web of Science ®Google Scholar
• Shimazaki C., Inaba T., Shimura K., Okamoto A., Takahashi R., Hirai H., Sudo Y., Ashihara E., Adachi Y., Murakami S., Saigo K., Fujita N., Nakagawa M. B-cell lymphoma associated with haemophagocytic syndrome: A clinical, immunological and cytogenetic study. British Journal of Haematology 1999; 104: 672–679
   PubMed Web of Science ®Google Scholar
• Shimazaki C., Inaba T., Nakagawa M. B-cell lymphoma-associated hemophagocytic syndrome. Leukemia and Lymphoma 2000; 38: 121–130
   PubMed Web of Science ®Google Scholar
• Bergman Y., Levy R. Biosynthesis and processing of a human T lymphocyte antigen. Journal of Immunology 1982; 128: 1334–1340
   PubMed Web of Science ®Google Scholar
• Haynes B. F., Denning S. M., Singer K. H., Kurtzberg J. Ontogeny of T-cell precursors: A model for the initial stages of human T-cell development. Immunology Today 1989; 10: 87–91
   PubMedGoogle Scholar
• Bradstock K. F., Kirk J., Grimsley P. G., Kabral A., Hughes W. G. Unusual immunophenotypes in acute leukemias: Incidence and clinical correlations. British Journal of Haematology 1989; 72: 512–518
   PubMed Web of Science ®Google Scholar
• Schroff R. W., Foon K. A. Heterogeneity in a lymphoid tumor: Coexpression of T and B surface markers. Blood 1982; 60: 373–380
   PubMed Web of Science ®Google Scholar
• Perl A., Szigeti A., Gergely P., Feher J., Magyarosi E., Sellyei M. Abrogation by chemotherapy of T-cell antigen expression in B-cell chronic lymphocytic leukaemia. New England Journal of Medicine 1986; 314: 186–187
   PubMed Web of Science ®Google Scholar
• Morabito F., Tassinari A., Callea V., Brugiatelli M., Fierro M. T., Saglio G., Neri A., Foa R. Germ-line configuration of the T-cell receptor beta-chain in B-cell chronic lymphoproliferative disorders which co-express T-cell antigens. European Journal of Haematology 1987; 3: 412–417
   Google Scholar
• Porwit A., Borgonovo L., Osby E., Lenkei R., Smith C. I., Hammarstrom L. B-cell chronic lymphocytic leukaemia with aberrant expression of CD8 antigen. European Journal of Haematology 1987; 39: 311–317
   PubMed Web of Science ®Google Scholar
• Ghosh K., Sivakumaran M., Wood J. K. Aberrant CD8 antigen expression in a patient with B chronic lymphocytic leukaemia showing unusual disease progression. British Journal of Haematology 1993; 85: 205–206
   PubMed Web of Science ®Google Scholar
• Koelliker D. D., Steele P. E., Hurtubise P. E., Flessa H. C., Sheng YP, Swerdlow S. H. CD8-positive B-cell chronic lymphocytic leukemia. A report of two cases. American Journal of Clinical Pathology 1994; 102: 212–216
   PubMed Web of Science ®Google Scholar
• Attadia V., Alosi M., Improta S., Baccarani M., De Paoli P. Immunophenotypic and molecular genetic characterization of a case of CD8+ B cell chronic lymphocytic leukemia. Leukemia 1996; 10: 1544–1550
   PubMed Web of Science ®Google Scholar
• Mulligan Dao S.P.L.P., Francis S. E., Thomas M. E., Gibson J., Cole-Sinclair M. F., Wolf M. B-cell chronic lymphocytic leukaemia with CD8 expression: Report of 10 cases and immunochemical analysis of the CD8 antigen. British Journal of Haematology 1998; 103: 157–162
   PubMed Web of Science ®Google Scholar
• Hoffman D. G., Tucker S. J., Emmanoulides C., Rosen P. A., Naeim F. CD8-positive mantle cell lymphoma: A report of two cases. American Journal of Clinical Pathology 1998; 109: 689–94
   PubMed Web of Science ®Google Scholar
• Noguchi M., Sakamoto N., Okumura K., Sato N., Yamada K., Isobe Y., Kato A., Oshimi K. CD8-positive diffuse large B-cell lymphoma. Japanese Journal of Clinical Hematology [in Japanese, abstract in English] 2000; 41: 590–594
   Google Scholar
• The International non-Hodgkin's Lymphoma Prognostic Factor Project. A predictive model for aggressive non-Hodgkin's lymphoma. New England Journal of Medicine 1993; 329: 987–994
   PubMed Web of Science ®Google Scholar
• Kita K., Miwa H., Nakase K., Kawakami K., Kobayashi T., Shirakawa S., Tanaka I., Ohta C., Tsutani H., Oguma S., Kyo T., Dohy H., Kamada N., Nasu K., Uchino H., The Japan Cooperative Group of Leukemia/Lymphoma. Clinical importance of CD7 expression in acute myelocytic leukemia. Blood 1993; 81: 2399–2405
   PubMed Web of Science ®Google Scholar
• Hardingham J. E., Kotasek D., Sage R. E., Dobrovic A., Gooley L. T., Dale B. M. Molecular detection of residual lymphoma cells in peripheral blood stem cell harvests and following autologous transplantation. Bone Marrow Transplantation 1993; 11: 15–20
   PubMed Web of Science ®Google Scholar
• Gribben J. G., Freedman A. S., Neuberg D., Roy D. C., Blake K. W., Woo S. D., Grossbard M. L., Rabinowe S. N., Coral F., Freeman G. D., Ritz J., Nadler L. M. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. New England Journal of Medicine 1991; 325: 1525–1533
   PubMed Web of Science ®Google Scholar
• Robertson L. E., Huh Y. O., Butler J. J., Pugh W. C., Hirsch G. C., Stass S., Kantarjian, Keating M. J. Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: Clinical, pathologic, immunophenotypic, and molecular analysis. Blood 1992; 80: 29–36
   PubMed Web of Science ®Google Scholar
• Berenson R. J., Bensinger W. I., Hill R. S., Andrews R. G., Lopez J. G., Kalamasz D. F., Still B. J., Spitzer G., Buckner C. D., Bernstein I. D., Thomas E. D. Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma. Blood 1991; 77: 1717–1722
   PubMed Web of Science ®Google Scholar
• Straka C., Drexler E., Mitterer M. Autotransplantation of B-cell purged peripheral blood progenitor cells in B-cell lymphoma. Lancet 1995; 345: 797–798
   PubMed Web of Science ®Google Scholar
• Ogura M., Kagami Y., Suzuki R., Miura K., Uehira K., Kurokawa T., Ito T., Kinoshita T., Emi N., Morishima Y., Kodera Y., Ueda R., Nagoya CD34+ PBSCT Study Group. Phase I/II trial of cure-oriented high-dose chemoradiotherapy with transplantation of CD34+ peripheral blood stem cells purified by the immunomagnetic bead method for refractory hematological malignancies. Cancer Chemotherapy and Pharmacology 1997; 40(Suppl)S51-S57
   PubMedGoogle Scholar
• Hsu C. C.S., Marti G. E., Schrek R., Williams R.C., Jr. Lymphocytes bearing B-and T-cell markers in patient with lymphosarcoma cell leukemia. Clinical Immunology and Immunopathology 1975; 3: 385–395
   PubMedGoogle Scholar
• Burns G. F., Nash A. A., Norman C. P., Barker C. R., Hayhoe F. G.J., Cawley J. C. A human leukaemic cell expressing hybrid membrane phenotypes. Nature 1977; 267: 243–245
   Web of Science ®Google Scholar
• Foan K. A., Bitting R. J., Terasaki P. I. Dual B and T markers in chronic lymphocytic leukemia. Blood 1980; 55: 16–20
   PubMed Web of Science ®Google Scholar
• Yancopoulos G. D., Blackwell T. K., Suh H., Hood L., Alt F. W. Introduced T cell receptor variable gene segments recombine in pre-B cells: Evidence that B and T cells use a common recombinase. Cell 1986; 44: 251–259
   PubMed Web of Science ®Google Scholar
• Foon K. A., Rai K. R., Gale R. P. Chronic lymphocytic leukemia: New insights into biology and therapy. Annals of Internal Medicine 1990; 113: 525–539
   PubMed Web of Science ®Google Scholar
• Mills K., Worman C., Cawley J. Normal human B cells express endogenous sheep erythrocyte (E) receptor after appropriate in vitro culture. European Journal of Immunology 1983; 13: 379–382
   PubMed Web of Science ®Google Scholar
• Mills K. H.G., Cawley J. C. Stimulated lymphoma cells of B lineage, but not plasma or myeloid cells, can express E receptor. Leukemia Research 1985; 9: 375–380
   PubMed Web of Science ®Google Scholar
• Antin J. H., Emerson S. G., Martin P., Gadol N., Ault K. A. Leu-1+ (CD5+) B cells: A major lymphoid sub-population in human fetal spleen: phenotypic and functional studies. Journal of Immunology 1986; 136: 505–510
   PubMed Web of Science ®Google Scholar
• Kipps T. J. The CD5 B cell. Advances in Immunology 1989; 47: 117–185
   PubMed Web of Science ®Google Scholar
• Kantor A. B. The development and repertoire of B-1 cells (CD5 B cells). Immunology Today 1991; 12: 389–391
   PubMedGoogle Scholar
• Grumayer E. R., Griesinger F., Hummell D. S., Brunning R. D., Kersey J. H. Identification of novel B-line-age cells in human fetal bone marrow that coexpress CD7. Blood 1991; 77: 64–68
   PubMed Web of Science ®Google Scholar
• Takahashi T., Hanai Y., Nosho K., Sohma T., Kabumoto T., Nishimura S., Hayashi T., Hinoda Y., Imai K. Chemotherapy-resistant CD7-positive stem cell lymphoma presenting with intra-abdominal mass. Japanese Journal of Clinical Hematology [in Japanese, abstract in English] 1998; 39: 1185–1189
   PubMedGoogle Scholar
• Farkas R., Ben-Efraim S., Manor Y., Zan-Bar I., Klajman A. Appearance of the T-cell marker CD8 on B chronic lymphatic leukemia cells in long-term cultures. Cancer Immunology Immunotherapy 1991; 34: 181–185
   PubMed Web of Science ®Google Scholar